On Friday, News Corp (NASDAQ:NWSA)’s shares declined -2.20% to $12.92.
News America Marketing, a partner of News Corp (NWSA), News America Marketing (NAM), the premier publisher of coupons in the U.S. and Canada, producing billions of coupons annually, declared that printing coupons from their popular savings website SmartSource.com is now simpler and easier than ever thanks to new coupon printing technology. The patented print solution allows consumers to print coupons without the burdensome requirement of downloading coupon printing software, making the process more streamlined while incorporating the controls needed to maintain coupon integrity and security.
After listening to consumer feedback and acknowledging the need for a new print-at-home solution, News America Marketing worked for over two years to formulate the ideal solution. The groundbreaking result is a patented solution that benefits both manufacturing and consumer constituencies by giving manufacturing clients the print security they need without requiring coupon printing software. The solution was soft-launched last month, and has seen print success improve by rates approaching 100% over the previous solution.
News Corporation, a media and information services company, focuses on creating and distributing content to consumers and businesses worldwide. The company distributes content and data products, such as The Wall Street Journal, Factiva, Dow Jones Risk & Compliance, Dow Jones Newswires, Barron’s, MarketWatch, Dow Jones Private Markets, and DJX through various media channels, counting newspapers, newswires, Websites, newsletters, magazines, proprietary databases, conferences, and video, in addition to applications for mobile devices, tablets, and electronic readers.
Idera Pharmaceuticals Inc (NASDAQ:IDRA)’s shares gained 8.62% to $3.78.
Idera Pharmaceuticals, Inc. (IDRA), a clinical-stage biopharmaceutical company developing Toll-like receptor (TLR) and RNA therapeutics for patients with cancer and rare diseases, recently declared new preclinical data that showed cancer immunotherapy with intratumoral injections of IMO-2125 alone and in combination with ipilimumab demonstrated potent and systemic anti-tumor activity in preclinical cancer models. IMO-2125 is a synthetic oligonucleotide-based agonist of Toll-like receptor 9 discovered and developed by Idera. Ipilimumab is a checkpoint inhibitor targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Additionally, Idera presented preclinical data which demonstrated that IMO-2125 induces a systemic antitumor immune response with the potential to sensitize the tumor microenvironment for combination with various checkpoint inhibitors. These data are being presented at the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference in New York City, starting recently.
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. It uses two proprietary drug discovery technology platforms to design and develop drug candidates, counting toll-like receptor targeting technology and gene silencing oligonucleotide (GSO) technology.
At the end of Friday’s trade, NetApp Inc. (NASDAQ:NTAP)‘s shares dipped -2.64% to $31.36.
NetApp, Inc. ( NTAP) released new details about its NetApp Insight® 2015 technical conference, a one-of-a-kind education and networking experience taking place October 12 to 15 in Las Vegas and November 16 to 19 in Berlin.
The company is happy to declare that the guest speaker is Chris Anderson, CEO of 3D Robotics, a best-selling author, and a former Wired editor-in-chief. Chris is also the founder of DIY Drones, an aerial robotics community with more than 40,000 members. Chris will share his entrepreneurial journey and his perspective on how data and drones inspire us to change the world.
At NetApp Insight in Las Vegas, Attendee Appreciation night will rock to the sounds of Grammy Award winning Train at the Mandalay Bay Beach, sponsored by Cisco and Fujitsu.
NetApp, Inc. provides software, systems, and services to manage and store computer data worldwide. It offers Data ONTAP storage operating system that delivers integrated data protection, comprehensive data administration, and built-in software for virtualized, shared infrastructures, cloud computing, and mixed workload business applications; E-Series storage systems for storage area network workloads (SAN); all-flash arrays that deliver input/output operations per second and ultralow latency to drive speed, responsiveness, and value from the applications that control key business operations; and hybrid arrays for mainstream business applications.
E*TRADE Financial Corp (NASDAQ:ETFC), ended its Friday’s trading session with -3.41% loss, and closed at $26.06.
E*TRADE Financial Corporation (ETFC) released its Monthly Activity Report for August 2015.
Daily Average Revenue Trades (“DARTs”) for August were 179,908, including a record trading day for the Company on August 24 with over 394,000 trades. August DARTs represented a 21 percent increase from July and a 23 percent increase from the year-ago period. The Company added 37,750 gross new brokerage accounts in August, and ended the month with approximately 3.2 million brokerage accounts — an increase of 14,038 from July.
Net new brokerage assets were $1.4 billion in the month. During the month, customer security holdings decreased by six percent, or $11.9 billion, and brokerage-related cash decreased by $0.3 billion to $40.9 billion. Bank-related cash and deposits decreased by $0.1 billion, ending the month at $5.4 billion. Customers were net buyers of approximately $1.3 billion in securities during the month.
E*TRADE Financial Corporation, a financial services company, provides brokerage and related products and services primarily to individual retail investors under the E*TRADE Financial brand name. It operates through two segments, Trading and Investing, and Balance Sheet Administration.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
